Mission Boys and Girls Club First Major Blind Tennis Tournament

The national recognition underscores the system's commitment to delivering exceptional cardiac care and life-saving outcomes for Rio Grande Valley patients.

From serving our nation to caring for patients across the Rio Grande Valley, nearly 100 veterans employed throughout South Texas Health System's (STHS) 12 facilities continue to make a difference through their work in healthcare.

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.